FDAnews
www.fdanews.com/articles/84895-atrium-biotechnologies-q4-profit-jumps-78-to-4m

ATRIUM BIOTECHNOLOGIES Q4 PROFIT JUMPS 78% TO $4M

February 28, 2006

Atrium Biotechnologies Inc. (TSX: ATB.SV) reported higher profits in the fourth quarter as the maker of specialty chemicals for the pharmaceutical, cosmetics and nutrition industries generated sharply higher revenues. The Quebec-based company said Tuesday its net earnings for the three months ended Dec. 31 rose 78 per cent to US$4.0 million or 14 cents a share, compared with US$2.3 million or 10 cents a share for the same period in 2004.

CBC.ca (http://www.cbc.ca/cp/business/060228/b022814.html)